Restricted accessResearch articleFirst published online 2018-10
Inhibitory Effects of Standardized Boesenbergia pandurata Extract and Its Active Compound Panduratin A on Lipopolysaccharide-Induced Periodontal Inflammation and Alveolar Bone Loss in Rats
Periodontitis, an inflammatory disease of the gingival tissue, triggered by microbial-derived elements, such as lipopolysaccharide (LPS), collapses the periodontal tissues and resorbs the alveolar bone. This study evaluated the inhibitory effects of standardized Boesenbergia pandurata extract (BPE) and panduratin A (PAN) on periodontitis-induced inflammation and alveolar bone loss. Sprague-Dawley rats with LPS-induced periodontitis were orally administered BPE (50 and 200 mg/kg/day) and PAN (20 mg/kg/day) for 8 days. Histological analysis revealed that BPE- and PAN-administered groups showed decreased cell infiltration and alveolar bone resorption. Furthermore, the BPE and PAN significantly alleviated the mRNA and protein expression levels of nuclear factor kappa B (NF-κB), interleukin-1β, matrix metalloproteinase (MMP)-2, and MMP-8. BPE and PAN also inhibited the expression of nuclear factor of activated T cells, cytoplasmic 1, c-Fos, and ostoclastogenesis-related enzymes, including cathepsin K and tartrate-resistant acid phosphatase (ALP). BPE and PAN not only upregulated the osteoblastogenesis-associated markers, such as collagen type I (COL1A1) and ALP, but also increased the ratio of osteoprotegerin to receptor activator of NF-κB ligand. Collectively, BPE and PAN efficiently prevent destruction of periodontal tissues and stimulating the loss of alveolar bone tissues, strongly indicative of their potential as natural antiperiodontitis agents.
Get full access to this article
View all access options for this article.
References
1.
NibaliL, FariasBC, VajgelA, et al.: Tooth loss in aggressive periodontitis: A systematic review. J Dent Res, 2013; 92:868–875.
2.
ChappleILC, GencoR: Diabetes and periodontal diseases: Consensus report of the joint EFP/AAP workshop on periodontitis and systemic diseases. J Clin Periodontol, 2013; 40:s106–s112.
3.
DietrichT, SharmaP, WalterC, et al.: The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol, 2013; 40:s70–s84.
4.
SinghraoSK, HardingA, PooleS, et al.: Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer's disease. Mediators of Inflamm, 2015; 2015:137357.
5.
GandhiM, KothiwaleS: Association of periodontal diseases with genetic polymorphisms. Int J Genet Eng, 2012; 2:19–27.
6.
HerathTD, DarveauRP, SeneviratneCJ, et al.: Tetra-and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts. PLoS One, 2013; 8:e58496.
7.
KoSY: Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells. Arch Oral Biol, 2012; 57:1623–1632.
8.
HienzSA, PaliwalS, IvanovskiS: Mechanisms of bone resorption in periodontitis. J Immunol Res, 2015; 2015:615486.
9.
WadaT, NakashimaT, HiroshiN, et al.: RANKL–RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med, 2006; 12:17–25.
10.
KimJH, KimN: Regulation of NFATc1 in osteoclast differentiation. J Bone Metab, 2014; 21:233–241.
11.
AsagiriM, SatoK, UsamiT, et al.: Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med, 2005; 202:1261–1269.
12.
ChahyadiA, HartatiR, WirasutisnaKR, et al.: Boesenbergia Pandurata Roxb., An Indonesian medicinal plant: Phytochemistry, biological activity, plant biotechnology. Proc Chem, 2014; 13:13–37.
13.
YunJM, KwonH, HwangJ: In vitro anti-inflammatory activity of panduratin A isolated from Kaempferia pandurata in RAW264.7 cells. Planta Med, 2003; 69:1102–1108.
14.
TewtrakulS, SubhadhirasakulS, KaralaiC, PonglimanontC, CheenprachaS: Anti-inflammatory effects of compounds from Kaempferia parviflora and Boesenbergia pandurata. Food Chem, 2009; 115:534–538.
15.
ShimJS, KwonYY, HanYS, et al.: Inhibitory effect of panduratin A on UV-induced activation of mitogen-activated protein kinases (MAPKs) in dermal fibroblast cells. Planta Med, 2008; 74:1446–1450.
16.
KimH, KimC, KimD, ChungH, HwangJ: Inhibitory effects of Boesenbergia pandurata on age-related periodontal inflammation and alveolar bone loss in Fischer 344 rats. J Microbiol Biotechnol, 2018; 28:357–366.
17.
KlintströmE, Smedby Ö, KlintströmB, BrismarT, MorenoR: Trabecular bone histomorphometric measurements and contrast-to-noise ratio in CBCT. Dentomaxillofac Rad, 2014; 43:20140196.
18.
van HamersveltRW, SchilhamAM, EngelkeK, et al.: Accuracy of bone mineral density quantification using dual-layer spectral detector CT: A phantom study. Eur Radiol, 2017; 27:4351–4359.
19.
RobertsHC, MoseleyR, SloanAJ, YoudeSJ, WaddingtonRJ: Lipopolysaccharide alters decorin and biglycan synthesis in rat alveolar bone osteoblasts: Consequences for bone repair during periodontal disease. Eur J Oral Sci, 2008; 116:207–216.
20.
BartoldPM, NarayananAS: Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol 2000, 2006; 40:29–49.
21.
MaesoG, BravoM, BasconesA: Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva. Quintessence Int, 2007; 38:247–252.
22.
RaiB, KaurJ, JainR, et al.: Levels of gingival crevicular metalloproteinases-8 and-9 in periodontitis. Saudi Dent J, 2010; 22:129–131.
23.
BaekJM, KimJY, CheonYH, et al.: Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice. Molecules, 2014; 19:11628–11644.
24.
KimK, LeeSH, KimJH, et al.: NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol, 2008; 22:176–185.
25.
MariniF, ParriS, MasiL, et al.: COL1A1 Sp1 variation and bone phenotypes in an Italian population. Clin Cases Miner Bone Metab, 2013; 10:133.
26.
MartinTJ, SimsNA: RANKL/OPG; critical role in bone physiology. Rev Endocr Metab Disor, 2015; 16:131–139.
27.
TsaiHT, ChangWL, TuHP, et al.: Effects of Salvia miltiorrhiza ethanolic extract on lipopolysaccharide-induced dental alveolar bone resorption in rats. J Dent Sci, 2016; 11:35–40.
28.
AlshwerfAO, AminLES, IbrahimF, et al.: Protective effect of Moringa oleifera extract on experimentally LPS-induced periodontitis. Int J Adv Res, 2017; 5:1734–1740.
29.
ZhangY, YanM, YuQF, et al.: Puerarin prevents LPS-induced osteoclast formation and bone loss via inhibition of Akt activation. Biol Pharm Bull, 2016; 39:2028–2035.
30.
KaraA, AkmanS, OzkanlarS, et al.: Immune modulatory and antioxidant effects of melatonin in experimental periodontitis in rats. Free Radic Biol Med, 2013; 55:21–26.
31.
ChengWC, HuangRY, ChiangCY, et al.: Ameliorative effect of quercetin on the destruction caused by experimental periodontitis in rats. J Periodontal Res, 2010; 45:788–795.
32.
BaekJM, KimJY, JungY, et al.: Mollugin from Rubea cordifolia suppresses receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorbing activity in vitro and prevents lipopolysaccharide-induced bone loss in vivo. Phytomedicine, 2015; 22:27–35.
33.
OzdemirH, KaraMI, ErciyasK, et al.: Preventive effects of thymoquinone in a rat periodontitis model: A morphometric and histopathological study. J Periodontal Res, 2012; 47:74–80.
